WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Web Hosting Domain Name Industry Sunday, October 25, 2020 
Add Press Release News | News Feeds Feeds | Email This News Email


World Market for Continuous Manufacturing for Biologics and Small Molecules 2020-2030
Tuesday, September 22, 2020

DUBLIN, Sept. 14, 2020 /PRNewswire/ -- The "Continuous Manufacturing Market (Small Molecules and Biologics), 2020 - 2030" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Recent advances in manufacturing technologies have prompted pharmaceutical companies to shift from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing. Continuous manufacturing, also known as continuous flow chemistry, is an advanced manufacturing technology, which drives operations in a continuous manner (247) in one facility, without hold times. The concept was first described in the 1700s, in relation to the production of pig iron in blast furnaces. Since then, the technique has been used in various industries, including automotive, food and beverage, oil refining, chemicals, pulp and paper, electronics, metal smelting, steel making, and waste-water treatment industries. In recent years, continuous manufacturing is becoming popular within the biopharmaceutical industry as well, having captured the attention of many big pharma players, as well as leading contract manufacturing organizations (CMOs). The key benefits associated with the adoption of continuous manufacturing technology include reduction in manufacturing cost (by 15-30%), reduction in manpower (by 50-70%), less product deviation (by 50%), smaller footprint requirement (by 50-70%), reduction in power consumption (by 40%) and faster scale up. Specifically for biologics, continuous manufacturing, through upstream perfusion, is already a well-established field; this can be justified by the fact that, till now, more than 20 biologics manufactured based on this approach have been approved by the FDA. On the other hand, for oral solid dosage (OSD) forms and small molecules, continuous processing technology presents a versatile and beneficial manufacturing approach.

There are several technology providers/equipment suppliers, offering the necessary technologies and equipment for continuous manufacturing, such as continuous flow reactors (plug flow reactors, continuous stirred tank reactors (CSTR) and microreactors), continuous granulators, continuous coaters, continuous mixers/blenders, continuous chromatography equipment, continuous dryers and process analytical technologies (PAT). In addition, many companies have made heavy investments in order to install this technology and expand their facilities and capabilities in this regard. Moreover, innovators engaged in this field have received significant support in the form of grants from various administering institutes and incentives from key regulatory agencies as well. Despite the challenges associated with the adoption of this technology (such as cost of equipment, process development restrictions, manufacturing of a new facility and maintenance of the equipment), we believe that the opportunity for both technology developers and manufacturers/users engaged in this domain is likely to grow in the foreseen future. In fact, the ongoing COVID-19 crisis is expected to accelerate the industry's shift towards advanced manufacturing platforms including continuous manufacturing.

The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE

5. COMPANIES WITH EXPERTISE IN CONTINUOUS MANUFACTURING IN NORTH AMERICA: PROFILES

6. COMPANIES WITH EXPERTISE IN CONTINUOUS MANUFACTURING IN EUROPE: PROFILES

7. COMPANIES WITH EXPERTISE IN CONTINUOUS MANUFACTURING IN ASIA-PACIFIC: PROFILES

8. RECENT PARTNERSHIPS AND COLLABORATIONS

9. RECENT EXPANSIONS

10. CAPACITY ANALYSIS

11. ACADEMIC GRANT ANALYSIS

12. PATENT ANALYSIS

13. INITIATIVES OF COMPANIES WITH IN-HOUSE CONTINUOUS MANUFACTURING CAPABILITIES

14. CASE STUDY: MODULAR FACILITIES IN PHARMACEUTICAL/BIOTECHNOLOGY INDUSTRY

15. CASE STUDY: TECHNOLOGY AND EQUIPMENT PROVIDERS

16. CASE STUDY: ROADMAP FOR THE ADOPTION OF CONTINUOUS MANUFACTURING PROCESSES

17. MARKET FORECAST AND OPPORTUNITY ANALYSIS

18. CONCLUSION

19. EXECUTIVE INSIGHT

Companies Mentioned

    --  3P Biopharmaceuticals
    --  Abbott
    --  AbbVie
    --  ABN Cleanroom Technology
    --  AC Immune
    --  Acasti Pharma
    --  ADC Biotechnology
    --  ADDvise Group
    --  ADMARES
    --  AES Clean Technology
    --  Aether
    --  Airgas
    --  Ajinomoto
    --  Albian Group
    --  Alconbury Weston
    --  AMPAC Fine chemicals
    --  AMRI
    --  Angelini Pharma
    --  Angstrom Technology
    --  Arcinova
    --  AstraZeneca
    --  Asymchem
    --  Clestra Cleanroom
    --  Filtration Technology
    --  Flowid
    --  FlowRHEX
    --  KinetiChem
    --  Kingspan
    --  Knowles Group
    --  Konkuk University
    --  KORSCH
    --  L.B. Bohle Maschinen+ Verfahren
    --  Lasco Services
    --  Microflow CVO
    --  Microinnova
    --  Microzone Corporation
    --  Modular Cleanrooms
    --  ModWave
    --  MRC Systems
    --  MTX Contracts
    --  Munson Machinery
    --  Novasep
    --  Nuvonis Technologies
    --  OCTANORM
    --  PaxVax
    --  Pentec Health
    --  Pfizer
    --  PharmaBlock Sciences
    --  Pharmadule Morimatsu
    --  Plascore
    --  Porsche Consulting
    --  PortaFab
    --  Porta-King Building Systems
    --  Precision Cleanrooms
    --  Precision NanoSystems
    --  Skender
    --  Snapdragon Chemistry
    --  Shelving + Rack Systems
    --  Starrco
    --  STEELife
    --  Stefatos
    --  Sterling Pharma
    --  Stodec Products
    --  Stragen Pharma
    --  Strike Bio
    --  Synthelia Organics
    --  Syrris
    --  Ted Thorsen Material Handling
    --  Telstar Life Science Solutions
    --  Weaver Technologies
    --  WH Partnership
    --  Windmill Cardiovascular Systems
    --  Wuxi AppTec
    --  Xytel
    --  YMC Process Technologies

For more information about this report visit https://www.researchandmarkets.com/r/b1jyzg

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/world-market-for-continuous-manufacturing-for-biologics-and-small-molecules-2020-2030-301128304.html

SOURCE Research and Markets



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Prometheus Group Announces Acquisition of SAP Partner, Utopia Global, Inc. | Oct 24, 2020
Nav SAP Partner Utopia Global, Inc. Announces Acquisition by Genstar-Backed Prometheus Group | Oct 24, 2020
Nav Clarivate Announces Winner of the 2020 Eugene Garfield Award | Oct 24, 2020
Nav Benn, Haro & Isaacs Law Firm to Rebrand to Workinjuryrights.com | Oct 24, 2020
Nav Global Content Delivery Network (CDN) Markets, 2019-2020 & Forecast to 2025: Benefits of CDN Such as Decreased Loading Time, Website Latency and Handling of Traffic Spikes to Drive Growth | Oct 24, 2020
Nav Sorcero Expands Into New York Insurance Market With Selection by InsurTech NY | Oct 24, 2020
Nav Rebel.com Names Blair Cox as Chief Executive Officer | Oct 24, 2020
Nav Neo4j Announces First Graph Machine Learning for the Enterprise | Oct 24, 2020
Nav Situation Awareness System (SAS) Market to Reach $36.19 Billion, Globally, by 2026 at 6.8% CAGR: Allied Market Research | Oct 24, 2020
Nav Synopsys Accelerates Power Electronics System Design with Virtual Prototyping Solution | Oct 24, 2020
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News